Related Experiment Video
Updated: May 4, 2026
15:06
Synthesis of an Intein-mediated Artificial Protein Hydrogel
Published on: January 27, 2014
11.6K
Constructing hybrid protein zymogens through protective dendritic assembly
David Y W Ng1, Matthias Arzt, Yuzhou Wu
1Institute of Organic Chemistry III, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm (Germany); Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz (Germany).
Angewandte Chemie (International Ed. in English)
|December 31, 2013
Summary
Researchers developed pH-responsive dendrimer-enzyme complexes for smart therapeutics. These complexes protect enzyme activity, enhance cellular uptake, and enable targeted release for controlled cytotoxicity, opening new avenues in precision biotherapeutics.
Area of Science:
- Biochemistry
- Materials Science
- Nanotechnology
Background:
- Smart protein therapeutics require precise control over protein activity and cellular uptake.
- Developing novel delivery systems is crucial for enhancing therapeutic efficacy and minimizing off-target effects.
Purpose of the Study:
- To create pH-responsive hybrid dendrimer-enzyme complexes for controlled protein delivery.
- To investigate the self-assembly, pH-responsiveness, and cellular behavior of these novel constructs.
Main Methods:
- Self-assembly of pH-responsive dendrimer shells onto enzymes (trypsin, papain, DNase I) using boronic acid-salicyl hydroxamate interactions.
- Evaluation of reversible pH-dependent activity modulation (pH 5.0-7.4).
- Assessment of cellular uptake, intracellular localization, and cytotoxicity in A549 cells.
Main Results:
- Successfully formed reversible dendrimer-enzyme complexes with pH-controlled activity.
- Demonstrated efficient cellular uptake and colocalization in acidic compartments (endosomes/lysosomes).
- Showcased programmed intracellular protease release, inducing significant cytotoxicity.
Conclusions:
- Hybrid dendrimer-enzyme complexes offer a promising platform for smart protein therapeutics.
- pH-responsive assembly enables controlled enzyme activity and targeted intracellular delivery.
- This approach provides a new strategy for precision biotherapeutics with induced cytotoxicity.
Related Concept Videos
02:41Protein Complex Assembly
12.5K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
12.5K
01:31Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
01:30Assembly of Signaling Complexes
4.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
4.7K
01:57Protein Complexes with Interchangeable Parts
2.1K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.1K